Earlier this month Martin Shkreli, who became a household name in 2015 when, he as CEO of a tiny company called Turing Pharmaceuticals, raised the price of a drug used to treat a parasitic infection by more than 5,000%, was sentenced to seven years in prison for defrauding investors in two failed hedge funds. Black Friday Physical Store Sales Turn Out Better Than Expected Entitlements: The “Most Predictable Economic Crisis In History” Corporate Gross Debt Reduction Could Spell Trouble For Credit Markets Shkreli’s actions ignited a fierce debate about the tactics drug companies have been using to squeeze every last…
On This Page
